Delineation of the minimal encephalitogenic epitope of proteolipid protein peptide91-110 and critical residues required for induction of EAE in HLA-DR3 transgenic mice

Journal of Neuroimmunology

Volumn 161, Issue 1-2, 2005, Pages 40-48

  Mangalam, Ashutosh K ^a   Khare, Meenakshi ^a   Krco, Christopher J ^a   Rodriguez, Moses ^a   David, Chella S ^a  

^a MAYO CLINIC   (United States)

Author keywords

EAE MS; Epitopes; MHC; Proteolipid protein (PLP); Transgenic mice

Indexed keywords

ALANINE; ASPARTIC ACID; ENCEPHALITOGENIC PROTEIN; HLA DR3 ANTIGEN; ISOLEUCINE; LYSINE; PROTEOLIPID PROTEIN;

ALLERGIC ENCEPHALOMYELITIS; AMINO ACID SUBSTITUTION; ANIMAL CELL; ANIMAL MODEL; ANIMAL TISSUE; ANTIGEN BINDING; ARTICLE; CONTROLLED STUDY; IMMUNE RESPONSE; MOUSE; NONHUMAN; PRIORITY JOURNAL; TRANSGENIC MOUSE;

EID: 14844290264     PISSN: 01655728     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jneuroim.2004.12.012     Document Type: Article

References (46)

1. C. Alvarado-de la Barrera, J. Zuniga-Ramos, J.A. Ruiz-Morales, B. Estanol, J. Granados, and L. Llorente HLA class II genotypes in Mexican mestizos with familial and nonfamilial multiple sclerosis Neurology 55 2000 1897 1900
2. P. Das, K.M. Drescher, A. Geluk, D.S. Bradley, M. Rodriguez, and C.S. David Complementation between specific HLA-DR and HLA-DQ genes in transgenic mice determines susceptibility to experimental autoimmune encephalomyelitis Hum. Immunol. 61 2000 279 289
3. B.A. de Jong, T.W. Huizinga, E. Zanelli, M.J. Giphart, E.L. Bollen, B.M. Uitdehaag, C.H. Polman, and R.G. Westendorp Evidence for additional genetic risk indicators of relapse-onset MS within the HLA region Neurology 59 2002 549 555
4. K.M. Drescher, P.D. Murray, C.S. David, L.R. Pease, and M. Rodriguez CNS cell populations are protected from virus-induced pathology by distinct arms of the immune system Brain Pathol. 9 1999 21 31
5. P. Duquette, F. Decary, J. Pleines, D. Boivin, G. Lamoureux, J.B. Cosgrove, and Y. Lapierre Clinical sub-groups of multiple sclerosis in relation to HLA: DR alleles as possible markers of disease progression Can. J. Neurol. Sci. 12 1985 106 110
6. M. Endoh, S.I. Rapoport, and T. Tabira Studies of experimental allergic encephalomyelitis in old mice J. Neuroimmunol. 29 1990 21 31
7. M.L. Ford, and B.D. Evavold An MHC anchor-substituted analog of myelin oligodendrocyte glycoprotein 35-55 induces IFN-gamma and autoantibodies in the absence of experimental autoimmune encephalomyelitis and optic neuritis Eur. J. Immunol. 34 2004 388 397
8. T.G. Forsthuber, C.L. Shive, W. Wienhold, K. de Graaf, E.G. Spack, R. Sublett, A. Melms, J. Kort, M.K. Racke, and R. Weissert T cell epitopes of human myelin oligodendrocyte glycoprotein identified in HLA-DR4 (DRB1*0401) transgenic mice are encephalitogenic and are presented by human B cells J. Immunol. 167 2001 7119 7125
9. A. Geluk, K.E. Van Meijgaarden, A.A. Janson, J.W. Drijfhout, R.H. Meloen, R.R. De Vries, and T.H. Ottenhoff Functional analysis of DR17(DR3)-restricted mycobacterial T cell epitopes reveals DR17-binding motif and enables the design of allele-specific competitor peptides J. Immunol. 149 1992 2864 2871
10. A. Geluk, K.E. van Meijgaarden, S. Southwood, C. Oseroff, J.W. Drijfhout, R.R. de Vries, T.H. Ottenhoff, and A. Sette HLA-DR3 molecules can bind peptides carrying two alternative specific submotifs J. Immunol. 152 1994 5742 5748
11. B. Georges, H. Gras-Masse, P. Maes, A. Capron, A. Tartar, and C. Auriault Analysis of peptides associated with class II MHC molecules, HLA-DR3: implication for the prediction of peptides useful for vaccines C. R. Acad. Sci., Ser. 3 Sci. vie 319 1996 1119 1125
12. J.M. Greer, and M.B. Lees Myelin proteolipid protein-the first 50 years Int. J. Biochem. Cell Biol. 34 2002 211 215
13. J. Hammer, P. Valsasnini, K. Tolba, D. Bolin, J. Higelin, B. Takacs, and F. Sinigaglia Promiscuous and allele-specific anchors in HLA-DR-binding peptides Cell 74 1993 197 203
14. J. Hammer, Z.A. Nagy, and F. Sinigaglia Rules governing peptide-class II MHC molecule interactions Behring-Inst.-Mitt. 1994 124 132
15. K. Ito, H.J. Bian, M. Molina, J. Han, J. Magram, E. Saar, C. Belunis, D.R. Bolin, R. Arceo, R. Campbell, F. Falcioni, D. Vidovic, J. Hammer, and Z.A. Nagy HLA-DR4-IE chimeric class II transgenic, murine class II-deficient mice are susceptible to experimental allergic encephalomyelitis J. Exp. Med. 183 1996 2635 2644
16. K. Kawamura, T. Yamamura, K. Yokoyama, D.H. Chui, Y. Fukui, T. Sasazuki, H. Inoko, C.S. David, and T. Tabira Hla-DR2-restricted responses to proteolipid protein 95-116 peptide cause autoimmune encephalitis in transgenic mice J. Clin. Invest. 105 2000 977 984
17. L.S. Madsen, E.C. Andersson, L. Jansson, M. Krogsgaard, C.B. Andersen, J. Engberg, J.L. Strominger, A. Svejgaard, J.P. Hjorth, R. Holmdahl, K.W. Wucherpfennig, and L. Fugger A humanized model for multiple sclerosis using HLA-DR2 and a human T-cell receptor Nat. Genet. 23 1999 343 347
18. G. Malcherek, V. Gnau, S. Stevanovic, H.G. Rammensee, G. Jung, and A. Melms Analysis of allele-specific contact sites of natural HLA-DR17 ligands J. Immunol. 153 1994 1141 1149
19. A.K. Mangalam, M. Khare, C. Krco, M. Rodriguez, and C. David Identification of T cell epitopes on human proteolipid protein and induction of experimental autoimmune encephalomyelitis in HLA class II-transgenic mice Eur. J. Immunol. 34 2004 280 290
20. S. Markovic-Plese, H. Fukaura, J. Zhang, A. al-Sabbagh, S. Southwood, A. Sette, V.K. Kuchroo, and D.A. Hafler T cell recognition of immunodominant and cryptic proteolipid protein epitopes in humans J. Immunol. 155 1995 982 992
21. M.G. Marrosu, F. Muntoni, M.R. Murru, G. Spinicci, M.P. Pischedda, F. Goddi, P. Cossu, and M. Pirastu Sardinian multiple sclerosis is associated with HLA-DR4: a serologic and molecular analysis Neurology 38 1988 1749 1753
22. M.G. Marrosu, M.R. Murru, G. Costa, F. Cucca, S. Sotgiu, G. Rosati, and F. Munton Multiple sclerosis in Sardinia is associated and in linkage disequilibrium with HLA-DR3 and -DR4 alleles Am. J. Hum Genet. 61 1997 454 457
23. M.G. Marrosu, M.R. Murru, G. Costa, R. Murru, F. Muntoni, and F. Cucca DRB1-DQA1-DQB1 loci and multiple sclerosis predisposition in the Sardinian population Hum. Mol. Genet. 7 1998 1235 1237
24. M.G. Marrosu, C. Motzo, R. Murru, R. Lampis, G. Costa, P. Zavattari, D. Contu, E. Fadda, E. Cocco, and F. Cucca The co-inheritance of type 1 diabetes and multiple sclerosis in Sardinia cannot be explained by genotype variation in the HLA region alone Hum. Mol. Genet. 13 2004 2919 2924
25. M. Minohara, H. Ochi, S. Matsushita, A. Irie, Y. Nishimura, and J. Kira Differences between T-cell reactivities to major myelin protein-derived peptides in opticospinal and conventional forms of multiple sclerosis and healthy controls Tissue Antigens 57 2001 447 456
26. T. Ohashi, T. Yamamura, J. Inobe, T. Kondo, T. Kunishita, and T. Tabira Analysis of proteolipid protein (PLP)-specific T cells in multiple sclerosis: identification of PLP 95-116 as an HLA-DR2,w15-associated determinant Int. Immunol. 7 1995 1771 1778
27. O. Olerup, J. Hillert, S. Fredrikson, T. Olsson, S. Kam-Hansen, E. Moller, B. Carlsson, and J. Wallin Primarily chronic progressive and relapsing/remitting multiple sclerosis: two immunogenetically distinct disease entities Proc. Natl. Acad. Sci. U. S. A. 86 1989 7113 7117
28. C.M. Pelfrey, J.L. Trotter, L.R. Tranquill, and H.F. McFarland Identification of a novel T cell epitope of human proteolipid protein (residues 40-60) recognized by proliferative and cytolytic CD4+ T cells from multiple sclerosis patients J. Neuroimmunol. 46 1993 33 42
29. C.M. Pelfrey, J.L. Trotter, L.R. Tranquill, and H.F. McFarland Identification of a second T cell epitope of human proteolipid protein (residues 89-106) recognized by proliferative and cytolytic CD4+ T cells from multiple sclerosis patients J. Neuroimmunol. 53 1994 153 161
30. C.M. Pelfrey, L.R. Tranquill, A.B. Vogt, and H.F. McFarland T cell response to two immunodominant proteolipid protein (PLP) peptides in multiple sclerosis patients and healthy controls Mult. Scler. 1 1996 270 278
31. T.R. Petersen, E. Bettelli, J. Sidney, A. Sette, V. Kuchroo, and B.T. Backstrom Characterization of MHC- and TCR-binding residues of the myelin oligodendrocyte glycoprotein 38-51 peptide Eur. J. Immunol. 34 2004 165 173
32. J.A. Quandt, M. Baig, K. Yao, K. Kawamura, J. Huh, S.K. Ludwin, H.J. Bian, M. Bryant, L. Quigley, Z.A. Nagy, H.F. McFarland, P.A. Muraro, R. Martin, and K. Ito Unique clinical and pathological features in HLA-DRB1*0401- restricted MBP 111-129-specific humanized TCR transgenic mice J. Exp. Med. 200 2004 223 234
33. H.G. Rammensee, T. Friede, and S. Stevanoviic MHC ligands and peptide motifs: first listing Immunogenetics 41 1995 178 228
34. C. Rich, J.M. Link, A. Zamora, H. Jacobsen, R. Meza-Romero, H. Offner, R. Jones, G.G. Burrows, L. Fugger, and A.A. Vandenbark Myelin oligodendrocyte glycoprotein-35-55 peptide induces severe chronic experimental autoimmune encephalomyelitis in HLA-DR2-transgenic mice Eur. J. Immunol. 34 2004 1251 1261
35. O. Rotzschke, K. Falk, S. Stevanovic, V. Gnau, G. Jung, and H.G. Rammensee Dominant aromatic/aliphatic C-terminal anchor in HLA-B*2702 and B*2705 peptide motifs Immunogenetics 39 1994 74 77
36. F. Sinigaglia, and J. Hammer Rules for peptide binding to MHC class II molecules Apmis 102 1994 241 248
37. R.A. Sobel, J.M. Greer, and V.K. Kuchroo Minireview: autoimmune responses to myelin proteolipid protein Neurochem. Res. 19 1994 915 921
38. L. Steinman Multiple sclerosis: a coordinated immunological attack against myelin in the central nervous system Cell 85 1996 299 302
39. G. Strauss, D.A. Vignali, G. Schonrich, and G.J. Hammerling Negative and positive selection by HLA-DR3(DRw17) molecules in transgenic mice Immunogenetics 40 1994 104 108
40. V.K. Tuohy Peptide determinants of myelin proteolipid protein (PLP) in autoimmune demyelinating disease: a review Neurochem. Res. 19 1994 935 944
41. V.K. Tuohy, Z. Lu, R.A. Sobel, R.A. Laursen, and M.B. Lees Identification of an encephalitogenic determinant of myelin proteolipid protein for SJL mice J. Immunol. 142 1989 1523 1527
42. S.M. Weenink, P.J. Milburn, and A.M. Gautam A continuous central motif of invariant chain peptides, CLIP, is essential for binding to various I-A MHC class II molecules Int. Immunol. 9 1997 317 325
43. B.G. Weinshenker, P. Santrach, A.S. Bissonet, S.K. McDonnell, D. Schaid, S.B. Moore, and M. Rodriguez Major histocompatibility complex class II alleles and the course and outcome of MS: a population-based study Neurology 51 1998 742 747
44. R.H. Whitham, R.E. Jones, G.A. Hashim, C.M. Hoy, R.Y. Wang, A.A. Vandenbark, and H. Offner Location of a new encephalitogenic epitope (residues 43 to 64) in proteolipid protein that induces relapsing experimental autoimmune encephalomyelitis in PL/J and (SJL×PL)F1 mice J. Immunol. 147 1991 3803 3808
45. S.S. Zamvil, and L. Steinman The T lymphocyte in experimental allergic encephalomyelitis Annu. Rev. Immunol. 8 1990 579 621
46. Y. Zhu, A.Y. Rudensky, A.L. Corper, L. Teyton, and I.A. Wilson Crystal structure of MHC class II I-Ab in complex with a human CLIP peptide: prediction of an I-Ab peptide-binding motif J. Mol. Biol. 326 2003 1157 1174